Snap Chart

Weight-Loss Drugs Aren't Just Changing Waistlines

A Bain survey shows GLP-1 drugs, like those known as Ozempic or Wegovy, lead to significant changes in consumer behavior that often persist even after consumers stop taking them.

  • First published on diciembre 16, 2024

Snap Chart

Weight-Loss Drugs Aren't Just Changing Waistlines
en

About the Research

Data powered by Dynata, a leading global first-party data and insights platform.

Industry Expertise

Explore Bain's expertise in Consumer Products and learn how we can help your company.

LEARN MORE
Grocery store interior with shoppers, a produce island, stocked shelves, and a refrigerated dairy section
Tags

Want to continue the conversation

We help global leaders with their organization's most critical issues and opportunities. Together, we create enduring change and results